Intralesional 3% sodium tetradecyl sulphate versus hot water in oral cavity hemangioma: a comparative study

Authors

  • Sayambika Mishra Department of ENT, VSS Institute of Medical Education and Research, Burla, Odisha, India
  • Souvagini Acharya Department of ENT, VSS Institute of Medical Education and Research, Burla, Odisha, India
  • Arunima Kar Department of ENT, VSS Institute of Medical Education and Research, Burla, Odisha, India
  • Fakir Mohan Mohanta Department of ENT, VSS Institute of Medical Education and Research, Burla, Odisha, India
  • Smruti Ranjan Samal Department of ENT, VSS Institute of Medical Education and Research, Burla, Odisha, India

DOI:

https://doi.org/10.18203/issn.2454-5929.ijohns20214228

Keywords:

Hemangioma, Sclerotherapy, 3% sodium tetradecyl sulphate, Hot water

Abstract

Background: Oral cavity lesions fall among the few most common presentations in the outpatient department of ENT. Hemangioma in oral cavity though do not usually account for any life threatening or serious condition but hampers day to day activities like chewing, speaking and occasionally bleeding from oral cavity. Timely diagnosis and treatment solves the above problem. Though there are various modalities of treatment ranging from cryosurgery to surgical ablation, sclerotherapy is an evolving, effective and easy method for reduction of the size of lesion and preventing recurrence. It can be done as a day care procedure. The aim was to compare between the efficacy of 3% sodium tetradecyl sulphate and hot water in oral cavity hemangiomas.

Methods: A total of 20 patients presenting to the OPD, department of ENT, VIMSAR, Burla, with diagnosis of hemangioma in oral cavity between January 2018 to January 2019 were selected for the study. They were divided into two groups. Group A was administered 3% sodium tetradecyl sulphate whereas group B was administered hot water, both intralesionally, at multiple sites of lesion. Injection were repeated after an interval of 2 weeks for a period of 3-4 months. The results were routinely analysed clinically and statistically and the statistical significance was set at p<0.05.

Results: There was a significant improvement (p<0.05) in most of the parameters measured, in group A patients as compared to group B patients.

Conclusions: 3% sodium tetradecyl sulphate is a better sclerosing agent than hot water in cases of oral cavity hemangiomas.

References

Whitehead KJ, Smith MC, Li DY. Arteriovenous malformations and other vascular malformation. Cold Spring Harb Perspect Med. 2013:3.

Jeyraj P, Chakranarayan A. Management of vascular malformations of maxillofacial region using sclerotherapy and sclerothrombotic therapy. Acta Scient Dent Sci. 2017;1(3):10-8.

Hazarika P, Nayak DR, Balakrishnan R. Textbook of ear, nose, throat and head and neck surgery. 2nd ed. India: CBS Press; 2009.

Gleeson M. Scott-Brown’s Otorhinolaryngology, head and neck surgery. 7th ed. Great Britain: Hodden Arnold; 2008.

Panditray S, Acharya S. Management of head and neck hemangiomas in adults; oral propranolol versus oral itraconazole in conjuction with injection sodium tetradecyl sulphate. Indian J Otolaryngol Head Neck Surg. 2019;71(1):566-73.

Manzano B, Premoli A. Sclerotherapy as an esthetic indication in oral vascular malformation: a case series. An Bras Dermatol. 2019;94(5):521-6.

Alakailly X, Kummoona R. Use of sodium tetradecyl sulphate in head and neck venous malforamtions. J Max Fac Oral Surg. 2015;14(2):332-8.

Mgbeokwere U, Egwuom O. Novel approach in preventing severe hemorrhage during extirpation of deep vascular malformations of face. An Med Health Sci Res. 2012;2(1):1-4.

Downloads

Published

2021-10-26

Issue

Section

Original Research Articles